Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Amanda Brandow DO

Amanda Brandow DO profile photo picture


Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology and Oncology - Pediatrics
Program: Hematology

Member of the Neuroscience Research Center

Research Experience

  • Pain in Sickle Cell Disease
  • Clinical Expertise

  • Hematology
  • Sickle Cell Disease
  • Publications (40)

  • American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. (Brandow AM, Carroll CP, Creary S, Edwards-Elliott R, Glassberg J, Hurley RW, Kutlar A, Seisa M, Stinson J, Strouse JJ, Yusuf F, Zempsky W, Lang E) Blood Adv 2020 Jun 23;4(12):2656-2701 PMID: 32559294 PMCID: PMC7322963 06/20/2020    
  • End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain. (Farrell AT, Panepinto J, Carroll CP, Darbari DS, Desai AA, King AA, Adams RJ, Barber TD, Brandow AM, DeBaun MR, Donahue MJ, Gupta K, Hankins JS, Kameka M, Kirkham FJ, Luksenburg H, Miller S, Oneal PA, Rees DC, Setse R, Sheehan VA, Strouse J, Stucky CL, Werner EM, Wood JC, Zempsky WT) Blood Adv 2019 12 10;3(23):3982-4001 PMID: 31809538 PMCID: PMC6963237 SCOPUS ID: 2-s2.0-85076356716 12/07/2019       2 Citations
  • 2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations. (Murad MH, Liem RI, Lang ES, Akl EA, Meerpohl JJ, DeBaun MR, Tisdale JF, Brandow AM, Lanzkron SM, Chou ST, Webb S, Mustafa RA) Blood Adv 2019 12 10;3(23):3945-3950 PMID: 31794603 PMCID: PMC6963245 12/04/2019       4 Citations
  • Neuropathic pain in individuals with sickle cell disease. (Sharma D, Brandow AM) Neurosci Lett 2020 01 01;714:134445 PMID: 31454562 08/28/2019       1 Citation
  • Interventions for treating neuropathic pain in people with sickle cell disease. (Asnani MR, Francis DK, Brandow AM, Hammond Gabbadon CE, Ali A) Cochrane Database Syst Rev 2019 07 05;7:CD012943 PMID: 31273755 PMCID: PMC6609827 07/06/2019    
  • Gabapentin alleviates chronic spontaneous pain and acute hypoxia-related pain in a mouse model of sickle cell disease. (Sadler KE, Langer SN, Menzel AD, Moehring F, Erb AN, Brandow AM, Stucky CL) Br J Haematol 2019 10;187(2):246-260 PMID: 31247672 PMCID: PMC6786911 SCOPUS ID: 2-s2.0-85068153982 06/28/2019    
  • Longitudinal Trend in Emergency Department Reliance for Pain Among Sickle Cell Disease Patients in Wisconsin. (Singh A, Yan K, Brandow AM, Panepinto JA) J Pediatr Hematol Oncol 2019 10;41(7):e438-e442 PMID: 31219908 SCOPUS ID: 2-s2.0-85072747381 06/21/2019       3 Citations
  • Chronic pain in adults with sickle cell disease is associated with alterations in functional connectivity of the brain. (Karafin MS, Chen G, Wandersee NJ, Brandow AM, Hurley RW, Simpson P, Ward D, Li SJ, Field JJ) PLoS One 2019;14(5):e0216994 PMID: 31107926 PMCID: PMC6527293 SCOPUS ID: 2-s2.0-85066063764 05/21/2019       1 Citation
  • Children and adolescents with sickle cell disease have worse cold and mechanical hypersensitivity during acute painful events. (Brandow AM, Hansen K, Nugent M, Pan A, Panepinto JA, Stucky CL) Pain 2019 Feb;160(2):407-416 PMID: 30247266 PMCID: PMC6768435 SCOPUS ID: 2-s2.0-85060395341 09/25/2018       9 Citations
  • Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood. (Hankins JS, Estepp JH, Hodges JR, Villavicencio MA, Robison LL, Weiss MJ, Kang G, Schreiber JE, Porter JS, Kaste SC, Saving KL, Bryant PC, Deyo JE, Nottage KA, King AA, Brandow AM, Lebensburger JD, Adesina O, Chou ST, Zemel BS, Smeltzer MP, Wang WC, Gurney JG) Pediatr Blood Cancer 2018 09;65(9):e27228 PMID: 29797644 05/26/2018       12 Citations
  • Key Components of Pain Management for Children and Adults with Sickle Cell Disease. (Brandow AM, DeBaun MR) Hematol Oncol Clin North Am 2018 06;32(3):535-550 PMID: 29729787 PMCID: PMC6800257 05/08/2018       5 Citations
  • Responsiveness of Patient-Reported Outcome Measurement Information System (PROMIS) pain domains and disease-specific patient-reported outcome measures in children and adults with sickle cell disease. (Curtis S, Brandow AM) Hematology Am Soc Hematol Educ Program 2017 12 08;2017(1):542-545 PMID: 29222303 PMCID: PMC6142574 12/10/2017       1 Citation
  • Pain-measurement tools in sickle cell disease: where are we now? (Darbari DS, Brandow AM) Hematology Am Soc Hematol Educ Program 2017 12 08;2017(1):534-541 PMID: 29222302 PMCID: PMC6142608 12/10/2017       4 Citations
  • Sickle cell disease: a natural model of acute and chronic pain. (Brandow AM, Zappia KJ, Stucky CL) Pain 2017 04;158 Suppl 1:S79-S84 PMID: 28221286 PMCID: PMC5350013 SCOPUS ID: 2-s2.0-85028915679 02/22/2017       16 Citations
  • Patient-reported neuropathic pain in adolescent and young adult cancer patients. (Acquazzino MA, Igler EC, Dasgupta M, Simpson P, Browning MB, Brandow AM) Pediatr Blood Cancer 2017 03;64(3) PMID: 27896941 SCOPUS ID: 2-s2.0-85006275580 11/30/2016       1 Citation
  • Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use. (Brandow AM, Wandersee NJ, Dasgupta M, Hoffmann RG, Hillery CA, Stucky CL, Panepinto JA) Br J Haematol 2016 Oct;175(2):237-245 PMID: 27539682 PMCID: PMC5063705 SCOPUS ID: 2-s2.0-84994551716 08/20/2016       18 Citations
  • Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease. (Brandow AM, Nimmer M, Simmons T, Charles Casper T, Cook LJ, Chumpitazi CE, Paul Scott J, Panepinto JA, Brousseau DC) Am J Hematol 2016 12;91(12):1175-1180 PMID: 27517842 08/16/2016       15 Citations
  • Clinical Interpretation of Quantitative Sensory Testing as a Measure of Pain Sensitivity in Patients With Sickle Cell Disease. (Brandow AM, Panepinto JA) J Pediatr Hematol Oncol 2016 05;38(4):288-93 PMID: 26907660 PMCID: PMC4856159 02/26/2016       15 Citations
  • Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia. (Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA, Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee) J Clin Pharmacol 2016 Mar;56(3):298-306 PMID: 26201504 PMCID: PMC4892120 07/24/2015       5 Citations
  • Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature. (Brandow AM, Farley RA, Panepinto JA) Pediatr Blood Cancer 2015 Sep;62(9):1501-11 PMID: 25976161 PMCID: PMC4515148 05/16/2015       38 Citations
  • A Comparison of Pain Assessment Measures in Pediatric Sickle Cell Disease: Visual Analog Scale Versus Numeric Rating Scale. (Myrvik MP, Drendel AL, Brandow AM, Yan K, Hoffmann RG, Panepinto JA) J Pediatr Hematol Oncol 2015 Apr;37(3):190-4 PMID: 25575295 SCOPUS ID: 2-s2.0-84926407202 01/13/2015       13 Citations
  • Update on the use of hydroxyurea therapy in sickle cell disease. (Wong TE, Brandow AM, Lim W, Lottenberg R) Blood 2014 Dec 18;124(26):3850-7; quiz 4004 PMID: 25287707 PMCID: PMC4271176 10/08/2014       49 Citations
  • The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay. (Brandow AM, Farley RA, Dasgupta M, Hoffmann RG, Panepinto JA) J Pediatr Hematol Oncol 2015 Jan;37(1):10-5 PMID: 25222053 PMCID: PMC4270887 09/16/2014       16 Citations
  • Do difficulties in swallowing medication impede the use of hydroxyurea in children? (Bekele E, Thornburg CD, Brandow AM, Sharma M, Smaldone AM, Jin Z, Green NS) Pediatr Blood Cancer 2014 Sep;61(9):1536-9 PMID: 24753149 PMCID: PMC4184198 04/23/2014       11 Citations
  • Neuropathic pain in patients with sickle cell disease. (Brandow AM, Farley RA, Panepinto JA) Pediatr Blood Cancer 2014 Mar;61(3):512-7 PMID: 24167104 PMCID: PMC4357477 10/30/2013       48 Citations
  • Academic attainment findings in children with sickle cell disease. (Epping AS, Myrvik MP, Newby RF, Panepinto JA, Brandow AM, Scott JP) J Sch Health 2013 Aug;83(8):548-53 PMID: 23834606 07/10/2013       14 Citations
  • Clinically meaningful measurement of pain in children with sickle cell disease. (Myrvik MP, Brandow AM, Drendel AL, Yan K, Hoffmann RG, Panepinto JA) Pediatr Blood Cancer 2013 Oct;60(10):1689-95 PMID: 23776145 PMCID: PMC3993972 SCOPUS ID: 2-s2.0-84881538085 06/19/2013       20 Citations
  • Assessment of communication modes in patients and families with sickle cell disease. (Anderson C, Torres S, Gokuli S, Brandow AM, Panepinto JA) Pediatr Blood Cancer 2013 May;60(5):887 PMID: 23450782 03/02/2013       2 Citations
  • Patients with sickle cell disease have increased sensitivity to cold and heat. (Brandow AM, Stucky CL, Hillery CA, Hoffmann RG, Panepinto JA) Am J Hematol 2013 Jan;88(1):37-43 PMID: 23115062 PMCID: PMC3552380 SCOPUS ID: 2-s2.0-84871433814 11/02/2012       83 Citations
  • "Sickle Cell Disease in the Emergency Department: Atypical Complications and Management" (Brandow AM, Liem R) Clin Pediatr Emerg Med 2011 Sep 01;12(3):202-212 PMID: 21927581 PMCID: PMC3172721 09/20/2011    
  • Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease. (Brandow AM, Panepinto JA) Am J Hematol 2011 Sep;86(9):804-6 PMID: 21815183 PMCID: PMC3804029 08/05/2011       21 Citations
  • Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease. (Hillery CA, Kerstein PC, Vilceanu D, Barabas ME, Retherford D, Brandow AM, Wandersee NJ, Stucky CL) Blood 2011 Sep 22;118(12):3376-83 PMID: 21708890 PMCID: PMC3179403 SCOPUS ID: 2-s2.0-80053217106 06/29/2011       88 Citations
  • The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations. (Brandow AM, Weisman SJ, Panepinto JA) Pediatr Blood Cancer 2011 May;56(5):789-93 PMID: 21370412 PMCID: PMC3069506 03/04/2011       21 Citations
  • The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations. (Brandow AM et al.) Pediatr Blood Cancer 2010 Dec 15: PMID: 21162071 12/17/2010    
  • Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. (Brandow AM, Panepinto JA) Expert Rev Hematol 2010 Jun;3(3):255-60 PMID: 21082977 PMCID: PMC3793890 11/19/2010       37 Citations
  • Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization. (Brandow AM, Jirovec DL, Panepinto JA) Am J Hematol 2010 Aug;85(8):611-3 PMID: 20658592 PMCID: PMC2911651 07/27/2010       51 Citations
  • Vaso-occlusive painful events in sickle cell disease: impact on child well-being. (Brandow AM, Brousseau DC, Pajewski NM, Panepinto JA) Pediatr Blood Cancer 2010 Jan;54(1):92-7 PMID: 19653296 PMCID: PMC3114448 08/05/2009       59 Citations
  • Dissatisfaction with hospital care for children with sickle cell disease not due only to race and chronic disease. (Brousseau DC, Mukonje T, Brandow AM, Nimmer M, Panepinto JA) Pediatr Blood Cancer 2009 Aug;53(2):174-8 PMID: 19350642 04/08/2009       19 Citations
  • Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events. (Brandow AM, Brousseau DC, Panepinto JA) Br J Haematol 2009 Mar;144(5):782-8 PMID: 19055663 PMCID: PMC3118502 12/06/2008       31 Citations
  • Parental perception of quality of hospital care for children with sickle cell disease. (Kam J, Panepinto JA, Brandow AM, Brousseau DC) WMJ 2008 May;107(3):131-5 PMID: 18575097 06/26/2008       4 Citations
  • Last update: 08/05/2020
    jenkins-FCD Prod-480 9a4deaf152b0b06dd18151814fff2e18f6c05280